𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluation

✍ Scribed by Phillipe Lothaire; Evandro de Azambuja; Didier Dequanter; Yassine Lalami; Christos Sotiriou; Guy Andry; Gilberto Castro Jr; Ahmad Awada

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
155 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The aim of this article is to review recent developments in the biological understanding of head and neck squamous cell carcinomas.

Methods and results:

We describe the markers according to their function and their prognostic or predictive roles. some associations can be found between molecular markers and invasiveness, aggressiveness, degree of differentiation, and tumor stage, but only a few clinical studies have shown an impact on prognosis. in addition, despite an increasing number of articles relating to this topic, the small number of patients included in the studies reported reduces the clinical implications of these results. few studies applied a more comprehensive molecular analysis approach, such as dna microarrays or differential expression profiling by polymerase chain reaction, to identify a combination of markers that could be more informative than a single molecular marker.

Conclusion:

Some progress has been made with respect to molecular markers and head and neck cancers. translational and prospective, hypothesis-driven research must proceed with sufficient rigor to facilitate the clinical applicability of such results.

πŸ“œ SIMILAR VOLUMES

Pain as sign of recurrent disease in hea
Pain as sign of recurrent disease in head and neck squamous cell carcinoma
✍ Miriam Smit; Alfonsus J. M. Balm; Frans J. M. Hilgers; I. Bing Tan πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

## Abstract ## Background The role of pain in head and neck cancer is seldom addressed. This retrospective study examined in a group of 190 curatively treated patients to what extent pain complaints should be considered to be the first sign of recurrent disease. ## Methods The research populatio

Molecular markers predict outcome in squ
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation
✍ Guido B. van den Broek; Maarten Wildeman; Coen R.N. Rasch; Nicola Armstrong; Ed πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 141 KB πŸ‘ 1 views

## Abstract Not all patients with squamous cell carcinomas of the head and neck (HNSCC) benefit from concurrent cisplatin‐based chemoradiation, but reliable predictive markers for outcome after chemoradiation are scarce. We have investigated potential prognostic biomarkers for outcome in a large gr

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Targeted therapies in squamous cell carc
Targeted therapies in squamous cell carcinoma of the head and neck
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r